FDA cites risk, but MS patients seek unproven therapy
LOS ANGELES/NEW YORK A controversial treatment for multiple sclerosis has been linked by U.S. health regulators to serious injuries including stroke, paralysis or even death, prompting them to issue an official warning to patients and physicians earlier this year.
But California radiologist Michael Arata and other doctors are continuing to treat a condition dubbed "chronic cerebrospinal venous insufficiency," or CCSVI, on dozens of new patients, based on their conviction that it offers a better quality of life.
The experimental technique, introduced three years ago, uses angioplasty balloons or stents to open up narrowed and twisted veins in the neck and chest to help blood drain from the brain. In its warning last May, the Food and Drug Administration said there is no clear evidence CCSVI exists in MS patients, and the procedure to treat it has not been shown to be safe or to help patients.
Arata argues that in 90 percent of about 1,200 cases he was involved in, the technique helped alleviate symptoms such as fatigue, "brain fog" and headache in patients suffering from MS, Parkinson's disease and other neurological conditions. Eighty of those treatments were delivered after the FDA warning, at a cost of up to $10,000 apiece, which is often not covered by insurance.
"I am convinced that there is a benefit," he added. "I am also convinced that it's safe."
Asked for comment on the continued use of CCSVI treatment, FDA spokeswoman Michelle Bolek said the agency does not regulate the practice of medicine and that doctors have significant leeway to use an approved medical device for treatments not specified on its label. The agency said doctors need to fully inform patients of the FDA's concerns.
"We are not seeking approval of a new use. This has nothing to do with the FDA," said Arata, who practices at Synergy Health Concepts in Newport Beach. "They have absolutely no jurisdiction."
DEGREE OF RISK
One of Arata's MS patients died after suffering bleeding in the brain several days after a CCSVI treatment last year. Arata attributed her death to the blood thinners used to prevent clots after CCSVI procedures, which he said have life-threatening effects in three or four out of 1,000 cases, compared with his experience of a single patient out of 1,200.
"If you have an invasive procedure, you can't take it lightly," Arata said. "We accept some degree of risk with any therapy."
Aisha Johnson, 35, was diagnosed with MS in 1997 and underwent CCSVI treatment by Arata earlier this month. She said she was informed of the FDA warning, but the hope of improvement won out.
"I have already noticed little changes. ... One day I was typing on the computer and halfway through kind of stopped and said, ‘Wait a minute, my hands aren't trembling as much,'" she said. "Every day I am kind of noticing little differences."
Synergy Health advertises its CCSVI procedures online, as does Community Care Physicians in Albany, New York, whose representatives did not respond to requests for comment. Experts familiar with the procedure said they knew of other doctors who had performed the treatment on patients since the FDA warning but would not provide names.
"There are some places that are doing it," said Dr. Robert Fox, staff neurologist and medical director at the Mellen Center for Multiple Sclerosis at Cleveland Clinic in Ohio. He warns his patients against the vein-opening treatment because "there have been more negative reports on the association of CCSVI with MS than there are positive."
A Canadian review of eight studies found wide variations in the degree to which CCSVI was detected in MS patients. Canada is preparing its own research into the effectiveness of the procedure on about 100 patients.
The FDA said it has received a report of one patient who died from bleeding in the brain and one who suffered permanent paralysis after CCSVI therapy. It cited a second death reported by medical journals, as well as serious complications such as blood clots and nerve damage.
Stanford University's CCSVI program was shut down in late 2009 after it acknowledged that one patient died of a brain hemorrhage and another needed emergency open-heart surgery after a stent migrated from the jugular vein to his heart. Last month two patients sued the university and Dr. Michael Dake, medical director of its catheterization and angiography laboratories, for performing dangerous experimental procedures on essentially healthy veins without properly informing patients of the risks.
"Dake really didn't consult with some of the other (doctors) who were further along with this," said Mark Wittwer, a co-plaintiff in that lawsuit who lost complete use of his right jugular vein. "A lot of this could have been avoided."
Stanford and Dake declined comment. Medical device maker Johnson & Johnson said it was not aware of its stents or angioplasty balloons being used for treating CCSVI, while Abbott Labs, which also makes those products, said it does not have a research program involving CCSVI. Officials at device maker Medtronic Inc did not respond to requests for comment.
QUESTIONING THE DATA
Multiple sclerosis has long been attributed to a glitch allowing the immune system to mistakenly attack the myelin sheath protecting nerve cells. It affects 2.5 million people globally with symptoms ranging from numbness or weakness in the limbs to loss of vision and an unsteady gait or even paralysis.
Current drugs act to delay the worsening of symptoms. Treatments like beta-interferon cause flu-like symptoms while a newer drug, Biogen's Tysabri, can cause a rare but fatal brain disease.
In 2009, Italian researcher Dr. Paolo Zamboni linked MS to CCSVI, a term he invented. The theory is that veins bringing blood from the brain and spine back to the heart become too narrow, causing some of that blood to leak into the brain tissue. Zamboni and his colleagues figured that might trigger inflammation, eventually leading to the balance and muscle problems seen in MS.
Zamboni did not respond to requests for comment.
Arata theorizes that the vein-opening treatment may help patients with a range of neurological conditions through its effect on the segment of the nervous system that controls involuntary actions.
The Cleveland Clinic is studying how best to diagnose CCSVI and whether dehydration has an impact on vein status, with some trial data due later this month at a conference in Lyon, France.
Some scientists have already made up their minds.
"If (CCSVI) were a risk factor, then it would be consistently found in patients with MS," said Klaus Schmierer, a neurologist at Queen Mary, University of London, who has worked on CCSVI studies.
In a recent report, the U.S. National MS Society wrote: "At this point, no connection has been confirmed between CCSVI and MS, in fact, CCSVI appears to occur in many people who do not have MS."
(Reporting by Deena Beasley and Genevra Pittman of Reuters Health; Editing by Michele Gershberg and Prudence Crowther)
LOS ANGELES/NEW YORK A controversial treatment for multiple sclerosis has been linked by U.S. health regulators to serious injuries including stroke, paralysis or even death, prompting them to issue an official warning to patients and physicians earl
n">The U.S. Food and Drug Administration said it was investigating a case of a rare and serious brain infection that developed in a patient in Europe, who was being treated with Novartis's multiple sclerosis drug, Gilenya. The FDA said this was th
WASHINGTON A GlaxoSmithKline Plc plant in Canada that makes the flu vaccine Flulaval has been cited by the U.S. Food and Drug Administration for failing to meet quality control standards. GSK said it is working to rectify the problems and does not ex
n">The first electronic automatic injector to deliver a drug for the most common form of multiple sclerosis received approval from the U.S. Food and Drug Administration on Friday. The injection delivers Betaseron, a disease-modifying drug approved
NEW YORK When senators met nearly a decade ago to consider the dangers of pharmacies that mix or alter drugs with little federal oversight, health officials briefed them on some alarming findings about the safety and efficacy of drugs made by these "
WASHINGTON U.S. drug reviewers recommended that regulators further study the effects in children of a group of medicines known as atypical antipsychotics, a report released on Friday said. Food and Drug Administration staff said a recent study of hea
COLLEGE PARK, Maryland An advisory panel on Tuesday rejected a Novartis AG drug for gout over concerns about side effects, a setback for the company's efforts to expand use of the medicine. A committee of Food and Drug Administration advisers voted 1
NEW YORK (Reuters Health) - Americans who receive a kidney from someone who is not a relative tend to be white, highly educated and live in wealthier neighborhoods, according to a new study that calls for wider outreach to promote living donation. Re
WASHINGTON/NEW YORK A deadly U.S. meningitis outbreak tied to contaminated steroid shots should spur new legislation to regulate how pharmacies mix and dose drugs, experts said on Monday. Health officials reported eight deaths and 105 cases of fungal
n">The U.S. Food and Drug Administration warned on Tuesday that the popular antibiotic azithromycin, sold as Zithromax, can cause a potentially fatal irregular heart rhythm in some patients. The agency said the move follows its review of a study b
n">Staff reviewers for the Food and Drug Administration did not recommend the approval of Abbott Laboratories' implantable heart device MitraClip, citing a lack of "valid scientific evidence" of safety and effectiveness. FDA reviewers sa
WASHINGTON The U.S. Food and Drug Administration said on Wednesday it has approved a new device to treat obesity, the first since 2007, sending shares of its maker, EnteroMedics Inc, up as much as 74 percent. Known as the Maestro Rechargeable System,
CHICAGO Heart patients are often given two or three different drugs to prevent life-threatening blood clots but these combinations can double, triple or even quadruple the risk of stomach or intestinal bleeding, U.S. researchers said on Tuesday. Clot
CHICAGO Younger Americans are being exposed to worrisome amounts of radiation from medical scans that increase their risk of cancer, U.S. researchers said on Wednesday. They said the cumulative risk of repeated exposure to radiation from medical scan
CHICAGO Roche AG's antiviral drug Tamiflu helped prevent deaths from seasonal flu in severely ill patients who had chronic underlying health problems, Chinese researchers said on Sunday. A study of 760 older, severely ill patients in Hong Kong found
LONDON Common asthma reliever drugs taken by millions of children around the world may increase the risk of asthma attacks in some patients with a particular genetic make-up, British scientists said on Tuesday. The researchers found that salbutamol,
WASHINGTON President Barack Obama asked on Monday for a 17 percent hike in the Food and Drug Administration's budget, but much of the increase would come from companies, not tax dollars. Almost half of the FDA's proposed $4.5 billion budget would com
CHICAGO Patients with blocked coronary arteries who opt for heart bypass surgery appear to live longer than those who choose a less-invasive stent procedure, according to a large study comparing the two treatments. The study found that among patients
NEW YORK (Reuters Health) - A therapy program focused on improving quality of life can help people being treated for advanced cancer, researchers from the Mayo Clinic in Rochester, Minnesota, have found. Patients who attended the sessions - a combina2012-09-14 CANCER
n">Treating HIV patients first with a chemotherapy drug improved their response to an experimental gene-modifying technique for controlling the virus, according to Sangamo BioSciences. The company presented new data from a small early-stage trial
- 10-261Warum fühle ich mich ganz anders die generische Form von Wellbutrin XL nehmen von den allgemeinen nehmen?
- 05-192Ich habe dabei, Tylenol PM immer meine Hüftoperation Sinse mir zu helfen, schlafen. Jetzt kann ich Harldy Schlaf. Hilfe
- 01-293Boston Scientific erhält 104m $ zurück in neue Vereinbarung mit Medinol
- 03-114Tiny Endoskopie-Kamera ist so klein wie ein Reiskorn
- 01-165Statin Medikamente zu Stimmungsschwankungen verbunden sind, Aggression bei Frauen
- 01-316"Spam" meat tied to diabetes risk in Native Americans: study
- 06-207Positive Psychologie Down Under: Die Māori
- 06-298Chronische Schmerzen und Schlafstörungen: Beenden Sie den Teufelskreis
- 06-30910 Potty Training Bücher für Kleinkinder
- 05-201Vitamin D may reduce decline in mental agility
- 11-232Kann Protonix in einem Werk im Zusammenhang mit Drogen-Test eine "positive" für THC geben?
- 09-293Forscher zeigen, dass Aufmerksamkeit unserer Realität verzerren
- 03-144Die niedrigsten Kalorien Pizza-Tipps für die Dieters
- 06-135First Response Digital Schwangerschaftstest Gold-
- 07-046Ultraschall-Nebelmaschine tötet Superbugs im gesamten Krankenhauszimmer in Minuten
- 09-207BREAKING: Bestimmte Medikamente Mord ... Mord Risiko erhöhte sich um 31% auf 200% ... 100 Millionen Amerikaner nehmen diese Medikamente zu begehen Menschen verursachen
- 10-088Amlodipine - Strange Sensation im Hals mit insgesamt 5 mg Norvasc?
- 10-189David Gorski extreme Arroganz, pathologischen Hass und völliger Missachtung entgegengesetzte Standpunkte macht ihn zu einer Gefahr für Karmanos Krebspatienten, warnt Autor
- Übelkeit / Erbrechen - Chemotherapie Induced - gibt es irgendwelche Übelkeit / Erbrechen Medikamente, die vermieden werden sollten
- Do video games fuel mental health problems?
- Warum leiden Menschen aus agralara?
- Eli Lilly verliert erste Runde Amylin Pharma (Morning Read)
- Wie Yoga unterscheidet sich von Stretching
- Gesundheitliche Vorteile von Saffron Extract
- Was ist eine Grippe-Epidemie?
- Candida-Diät - Lebensmittel zu vermeiden
- Meine Mutter leidet an einer schlechten Dickdarm und Bauchschmerzen?
- Essen in Mumbai nach den Anschlägen
- Ist Celebrex so gefährlich, wie mein neues Dokument versucht zu entziffern?
- Hat jemand Gewicht, während auf Cymbalta gewonnen?
- Meridian Bioscience Q4 Gewinn fallen 40%, Aktien im Trockner
- Ein Apotheker Epitaph? Lehren aus Eric Cropp (Wochenend-Runden)
- Die Vorteile von Berberin
- Hand Sanitizer kann Muskelkontraktions Impair
- Pro-Monsanto Bill Nye der "Wissenschaft Kerl", sagt GVO sind genial und Skeptiker des Klimawandels sollten ins Gefängnis geworfen werden ... ja, wirklich
- Atypische Depression ist eigentlich sehr Typische
- NEW YORK (Reuters Health) - People who want to reduce their risk of colon cancer may want to start exercising more and cutting down on red meat and alcohol, a new research review suggests. Such measures -- along with not smoking -- may be key lifesty
- CHICAGO Taking a moderate amount of salt may be healthier than too little or too much, researchers reported on Tuesday in a study likely to fuel the debate over the health effects of salt in the diet. Doctors for years have warned that high salt inta
Ich habe seit über einem Jahr auf Gewicht-Beobachter gewesen. Dann, wenn ich enbrel begann begann ich, Gewicht zu gewinnen?... Zurück. Weiß jemand, ob dies ein Nebeneffekt ist? ----schneiden---- In Antwort auf die Marvell bei 2012-03-09 22.31 Die Gewichtszunahme erscheint eine Nebenwirkung von Enbrel zu sein ... nicht eine sehr häufige Nebenwirkung. Andere Nebenwirkungen
- Das Bakterium, Enterococcus faecalis, die im menschlichen Darm lebt und ist eine führende Ursache von Antibiotika-resistenten Krankenhaus erworbenen bakteriellen Infektionen des Blutes, produziert virale Waffen, die dem Bakterium Rivalen Ziel, berich
- Wenn Sie an einer bipolaren Störung und erwägen, Kinder zu haben, eine der Fragen, die Sie wahrscheinlich fragen sich, ob Sie Ihre bipolare Störung auf, um ein Kind passieren würde. Sie haben wahrscheinlich gehört, dass bipolare Störung vererbt werde
- Ich nahm Losartan für 2 Monate, aber dann hatte allergische Reaktion. Die meisten Nebenwirkungen sind mit Ausnahme von nörgelnden dumpfe Schmerzen in der Brust weg. Geprüft mit docs sagte ok. Frage mich nur, wenn jemand mir helfen kann. ----schneiden
- Ich glaube, dass Langeweile eine wichtige Rolle bei der Jugend zu spielen, für gut und schlecht. Für gut ist, kann es ein Anreiz für die Entwicklung geworden, wie alt Aktivitäten Reiz und frische Interessen verlieren müssen gefunden werden, neues Wac
- Ariel Castro bekannte sich schuldig zu 900 zählt der Entführung und Vergewaltigung am Freitag und nahm einen Satz des Lebens ohne Bewährung. Obwohl er schließlich seine Verbrechen zugelassen, fragen wir uns doch, was möglicherweise zu dieser extremen
- Unsere neuesten humanitären Projekt umfasst Bildungsinformationsaustausch soll helfen, jemals passiert den nächsten Holocaust zu stoppen. Ich habe gerade zwei wichtige Lehrvideos Titel "The Divine Right of Self Defense" abgeschlossen und "G
- GENEVA Pakistan's failure to stem the spread of polio triggered global emergency health measures on Monday, with the World Health Organization (WHO) recommending all residents must show proof of vaccination before they can leave the country. The emer
- Wie Cetirizin Hydrochlorid-Tabletten wie alerid mit oralen Kontrazeptivums Tablette femilon interagieren?
- Hat Lotrel verursachen Probleme mit Haaren?
- Ich begann gerade ein neues Medikament namens SAPHRIS ist es besser als geodon?
- "Das eigentliche Problem ist Medicaid und Medicare Das ist der Alptraum-Szenario." Obama sagt Wisconsin - MedCity Morgen lesen, 12. Juni 2009
- Do Not Resuscitate (DNR) Bestellungen
- Gibt es eine Begrenzung für die Zeitdauer der Verwendung es?
- Nervenschmerzen nach Bauchchirurgie
- Spaß Valentinstag-Aktivitäten für Tweens
- Die möglichen Nebenwirkungen einer Hysterektomie
- Um schwanger, vermeiden Sie diese spannungsinduzierte Fertility Traps